1887

Abstract

Sequence comparison of the V/P and F genes of 13 human, canine, porcine and simian isolates of simian virus 5 (SV5) revealed a surprising lack of sequence variation at both the nucleotide and amino acid levels (0–3 %), even though the viruses were isolated over 30 years and originated from countries around the world. Furthermore, there were no clear distinguishing amino acid or nucleotide differences among the isolates that correlated completely with the species from which they were isolated. In addition, there was no evidence that the ability of the viruses to block interferon signalling by targeting STAT1 for degradation was confined to the species from which they were isolated. All isolates had an extended cytoplasmic tail in the F protein, compared with the original W3A and WR monkey isolates. Sequence analysis of viruses that were derived from human bone-marrow cells isolated in London in the 1980s revealed that, whilst they were related more closely to one another than to the other isolates, they all had identifying differences, suggesting that they were independent isolates. These results therefore support previous data suggesting that SV5 can infect humans persistently, although the relationship of SV5 to any human disease remains highly contentious. Given that SV5 has been isolated on multiple occasions from different species, it is proposed that the term simian virus 5 is inappropriate and suggested that the virus should be renamed parainfluenza virus 5.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80200-0
2004-10-01
2019-10-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/10/vir853007.html?itemId=/content/journal/jgv/10.1099/vir.0.80200-0&mimeType=html&fmt=ahah

References

  1. Andrejeva, J., Young, D. F., Goodbourn, S. & Randall, R. E. ( 2002; ). Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J Virol 76, 2159–2167.[CrossRef]
    [Google Scholar]
  2. Atoynatan, T. & Hsiung, G. D. ( 1969; ). Epidemiologic studies of latent virus infections in captive monkeys and baboons. II. Serologic evidence of myxovirus infections with special reference to SV5. Am J Epidemiol 89, 472–479.
    [Google Scholar]
  3. Azetaka, M. & Konishi, S. ( 1988; ). Kennel cough complex: confirmation and analysis of the outbreak in Japan. Nippon Juigaku Zasshi 50, 851–858.[CrossRef]
    [Google Scholar]
  4. Basle, M. F., Russell, W. C., Goswami, K. K. A., Rebel, A., Giraudon, P., Wild, F. & Filmon, R. ( 1985; ). Paramyxovirus antigens in osteoclasts from Paget's bone tissue detected by monoclonal antibodies. J Gen Virol 66, 2103–2110.[CrossRef]
    [Google Scholar]
  5. Baumgärtner, W. K., Metzler, A. E., Krakowka, S. & Koestner, A. ( 1981; ). In vitro identification and characterization of a virus isolated from a dog with neurological dysfunction. Infect Immun 31, 1177–1183.
    [Google Scholar]
  6. Baumgärtner, W. K., Krakowka, S., Koestner, A. & Evermann, J. ( 1982; ). Acute encephalitis and hydrocephalus in dogs caused by canine parainfluenza virus. Vet Pathol 19, 79–92.[CrossRef]
    [Google Scholar]
  7. Baumgärtner, W., Krakowka, S. & Blakeslee, J. ( 1987a; ). Evolution of in vitro persistence of two strains of canine parainfluenza virus. Brief report. Arch Virol 93, 147–154.[CrossRef]
    [Google Scholar]
  8. Baumgärtner, W., Krakowka, S. & Blakeslee, J. R. ( 1987b; ). Persistent infection of Vero cells by paramyxoviruses. A morphological and immunoelectron microscopic investigation. Intervirology 27, 218–223.[CrossRef]
    [Google Scholar]
  9. Baumgärtner, W., Krakowka, S. & Durchfeld, B. ( 1991; ). In vitro cytopathogenicity and in vivo virulence of two strains of canine parainfluenza virus. Vet Pathol 28, 324–331.[CrossRef]
    [Google Scholar]
  10. Behbehani, A. M., Melnick, J. L. & DeBakey, M. E. ( 1965; ). A paramyxovirus isolated from human atheromatous lesion. Exp Mol Pathol 4, 606–619.[CrossRef]
    [Google Scholar]
  11. Binn, L. N., Eddy, G. A., Lazar, E. C., Helms, J. & Murnane, T. ( 1967; ). Viruses recovered from laboratory dogs with respiratory disease. Proc Soc Exp Biol Med 126, 140–145.[CrossRef]
    [Google Scholar]
  12. Biron, C. A. & Sen, G. C. ( 2001; ). Interferons and other cytokines. In Fields Virology, 4th edn, pp. 321–349. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott-Raven.
  13. Chanock, R. M., Johnson, K. M., Cook, M. K., Wong, D. C. & Vargosko, A. ( 1961; ). The hemadsorption technique with a special reference to the problem of naturally occurring simian parainfluenza viruses. Am Rev Respir Dis 83, 125–129.
    [Google Scholar]
  14. Chatziandreou, N., Young, D., Andrejeva, J., Goodbourn, S. & Randall, R. E. ( 2002; ). Differences in interferon sensitivity and biological properties of two related isolates of simian virus 5: a model for virus persistence. Virology 293, 234–242.[CrossRef]
    [Google Scholar]
  15. Choppin, P. W. ( 1964; ). Multiplication of a myxovirus (SV5) with minimal cytopathic effects and without interference. Virology 23, 224–233.[CrossRef]
    [Google Scholar]
  16. Choppin, P. W. ( 1981; ). Isolation of paramyxoviruses from patients with chronic neurologic diseases. J Infect Dis 143, 501–503.[CrossRef]
    [Google Scholar]
  17. Cornwell, H. J., McCandlish, I. A., Thompson, H., Laird, H. M. & Wright, N. G. ( 1976; ). Isolation of parainfluenza virus SV5 from dogs with respiratory disease. Vet Rec 98, 301–302.[CrossRef]
    [Google Scholar]
  18. Didcock, L., Young, D. F., Goodbourn, S. & Randall, R. E. ( 1999a; ). Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis. J Virol 73, 3125–3133.
    [Google Scholar]
  19. Didcock, L., Young, D. F., Goodbourn, S. & Randall, R. E. ( 1999b; ). The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol 73, 9928–9933.
    [Google Scholar]
  20. Evermann, J. F., Lincoln, J. D. & McKiernan, A. J. ( 1980; ). Isolation of a paramyxovirus from the cerebrospinal fluid of a dog with posterior paresis. J Am Vet Med Assoc 177, 1132–1134.
    [Google Scholar]
  21. Evermann, J. F., Krakowka, S., McKeirnan, A. J. & Baumgärtner, W. ( 1981; ). Properties of an encephalitogenic canine parainfluenza virus. Arch Virol 68, 165–172.[CrossRef]
    [Google Scholar]
  22. Goodbourn, S., Didcock, L. & Randall, R. E. ( 2000; ). Interferons: cell signalling, immune modulation, antiviral responses and virus countermeasures. J Gen Virol 81, 2341–2364.
    [Google Scholar]
  23. Goswami, K. K. A., Lange, L. S., Mitchell, D. N., Cameron, K. R. & Russell, W. C. ( 1984; ). Does simian virus 5 infect humans? J Gen Virol 65, 1295–1303.[CrossRef]
    [Google Scholar]
  24. Goswami, K. K. A., Randall, R. E., Lange, L. S. & Russell, W. C. ( 1987; ). Antibodies against the paramyxovirus SV5 in the cerebrospinal fluids of some multiple sclerosis patients. Nature 327, 244–247.[CrossRef]
    [Google Scholar]
  25. He, B., Lin, G. Y., Durbin, J. E., Durbin, R. K. & Lamb, R. A. ( 2001; ). The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells. J Virol 75, 4068–4079.[CrossRef]
    [Google Scholar]
  26. He, B., Paterson, R. G., Stock, N., Durbin, J. E., Durbin, R. K., Goodbourn, S., Randall, R. E. & Lamb, R. A. ( 2002; ). Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-β induction and interferon signaling. Virology 303, 15–32.[CrossRef]
    [Google Scholar]
  27. Heinen, E., Herbst, W. & Schmeer, N. ( 1998; ). Isolation of a cytopathogenic virus from a case of porcine reproductive and respiratory syndrome (PRRS) and its characterization as parainfluenza virus type 2. Arch Virol 143, 2233–2239.[CrossRef]
    [Google Scholar]
  28. Horta-Barbosa, L., Fuccillo, D. A., Hamilton, R., Traub, R., Ley, A. & Sever, J. L. ( 1970; ). Some characteristics of SSPE measles virus. Proc Soc Exp Biol Med 134, 17–21.[CrossRef]
    [Google Scholar]
  29. Hsiung, G. D. ( 1972; ). Parainfluenza-5 virus. Infection of man and animal. Prog Med Virol 14, 241–274.
    [Google Scholar]
  30. Huddlestone, J. R., Sipe, J., Braheny, S., Jensen, F. C., McMillan, R., Lampert, P. & Oldstone, M. B. A. ( 1979; ). Failure to isolate a transmissible agent from the bone-marrow of patients with multiple sclerosis. Lancet ii, 415.
    [Google Scholar]
  31. Huelsenbeck, J. P., Ronquist, F., Nielsen, R. & Bollback, J. P. ( 2001; ). Bayesian inference of phylogeny and its impact on evolutionary biology. Science 294, 2310–2314.[CrossRef]
    [Google Scholar]
  32. Hull, R. N., Minner, J. R. & Smith, J. W. ( 1956; ). New viral agents recovered from tissue cultures of monkey cells. I. Origin and properties of cytopathogenic agents SV1, SV2, SV4, SV5, SV6, SV11, SV12 and SV15. Am J Hyg 63, 204–215.
    [Google Scholar]
  33. Ito, M., Nishio, M., Kawano, M., Kusagawa, S., Komada, H., Ito, Y. & Tsurudome, M. ( 1997; ). Role of a single amino acid at the amino terminus of the simian virus 5 F2 subunit in syncytium formation. J Virol 71, 9855–9858.
    [Google Scholar]
  34. Ito, M., Nishio, M., Komada, H., Ito, Y. & Tsurudome, M. ( 2000; ). An amino acid in the heptad repeat 1 domain is important for the haemagglutinin–neuraminidase-independent fusing activity of simian virus 5 fusion protein. J Gen Virol 81, 719–727.
    [Google Scholar]
  35. Lamb, R. A. & Kolakofsky, D. ( 2001; ). Paramyxoviridae: the viruses and their replication. In Fields Virology, 4th edn, pp. 1305–1340. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott-Raven.
  36. Levy, D. E. & García-Sastre, A. ( 2001; ). The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev 12, 143–156.[CrossRef]
    [Google Scholar]
  37. Liebhaber, H., Krugman, S., McGregor, D. & Giles, J. P. ( 1965; ). Studies of a myxovirus recovered from patients with infectious hepatitis. I. Isolation and characterization J Exp Med 122, 1135–1150.[CrossRef]
    [Google Scholar]
  38. Lim, C. S., Chan, K. P., Goh, K. T. & Chow, V. T. K. ( 2003; ). Hemagglutinin-neuraminidase sequence and phylogenetic analyses of mumps virus isolates from a vaccinated population in Singapore. J Med Virol 70, 287–292.[CrossRef]
    [Google Scholar]
  39. McCandlish, I. A., Thompson, H., Cornwell, H. J. & Wright, N. G. ( 1978; ). A study of dogs with kennel cough. Vet Rec 102, 293–301.[CrossRef]
    [Google Scholar]
  40. McLean, B. N. & Thompson, E. J. ( 1989; ). Antibodies against the paramyxovirus SV5 are not specific for cerebrospinal fluid from multiple sclerosis patients. J Neurol Sci 92, 261–266.[CrossRef]
    [Google Scholar]
  41. Parisien, J.-P., Lau, J. F. & Horvath, C. M. ( 2002; ). STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J Virol 76, 6435–6441.[CrossRef]
    [Google Scholar]
  42. Park, M.-S., García-Sastre, A., Cros, J. F., Basler, C. F. & Palese, P. ( 2003; ). Newcastle disease virus V protein is a determinant of host range restriction. J Virol 77, 9522–9532.[CrossRef]
    [Google Scholar]
  43. Paterson, R. G., Harris, T. J. R. & Lamb, R. A. ( 1984; ). Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc Natl Acad Sci U S A 81, 6706–6710.[CrossRef]
    [Google Scholar]
  44. Poole, E., He, B., Lamb, R. A., Randall, R. E. & Goodbourn, S. ( 2002; ). The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-β. Virology 303, 33–46.[CrossRef]
    [Google Scholar]
  45. Randall, R. E. & Young, D. F. ( 1988; ). Comparison between parainfluenza virus type 2 and simian virus 5: monoclonal antibodies reveal major antigenic differences. J Gen Virol 69, 2051–2060.[CrossRef]
    [Google Scholar]
  46. Randall, R. E. & Russell, W. C. ( 1991; ). Paramyxovirus persistence: consequences for host and virus. In The Paramyxoviruses, pp. 299–321. Edited by D. W. Kingsbury. New York: Plenum.
  47. Randall, R. E. & Bermingham, A. ( 1996; ). NP : P and NP : V interactions of the paramyxovirus simian virus 5 examined using a novel protein : protein capture assay. Virology 224, 121–129.[CrossRef]
    [Google Scholar]
  48. Randall, R. E., Young, D. F., Goswami, K. K. A. & Russell, W. C. ( 1987; ). Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates. J Gen Virol 68, 2769–2780.[CrossRef]
    [Google Scholar]
  49. Rima, B. K., Earle, J. A. P., Baczko, K. & 7 other authors ( 1997; ). Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J Gen Virol 78, 97–106.
    [Google Scholar]
  50. Robbins, S. J., Wrzos, H., Kline, A. L., Tenser, R. B. & Rapp, F. ( 1981; ). Rescue of a cytopathic paramyxovirus from peripheral blood leukocytes in subacute sclerosing panencephalitis. J Infect Dis 143, 396–403.[CrossRef]
    [Google Scholar]
  51. Ronquist, F. & Huelsenbeck, J. P. ( 2003; ). MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19, 1572–1574.[CrossRef]
    [Google Scholar]
  52. Rosenberg, F. J., Lief, F. S., Todd, J. D. & Reif, J. S. ( 1971; ). Studies of canine respiratory viruses. I. Experimental infection of dogs with an SV5-like canine parainfluenza agent. Am J Epidemiol 94, 147–165.
    [Google Scholar]
  53. Russell, W. C., Randall, R. E. & Goswami, K. K. A. ( 1989; ). Multiple sclerosis and paramyxovirus. Nature 340, 104.
    [Google Scholar]
  54. Sakaguchi, T., Toyoda, T., Gotoh, B., Inocencio, N. M., Kuma, K., Miyata, T. & Nagai, Y. ( 1989; ). Newcastle disease virus evolution. I. Multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase gene. Virology 169, 260–272.[CrossRef]
    [Google Scholar]
  55. Schultz, E. W. & Habel, K. ( 1959; ). SA virus; a new member of the myxovirus group. J Immunol 82, 274–278.
    [Google Scholar]
  56. Sen, G. C. ( 2001; ). Viruses and interferons. Annu Rev Microbiol 55, 255–281.[CrossRef]
    [Google Scholar]
  57. Seth, S., Vincent, A. & Compans, R. W. ( 2003; ). Mutations in the cytoplasmic domain of a paramyxovirus fusion glycoprotein rescue syncytium formation and eliminate the hemagglutinin-neuraminidase protein requirement for membrane fusion. J Virol 77, 167–178.[CrossRef]
    [Google Scholar]
  58. Siegl, G. & Hahn, E. E. ( 1969; ). A paramyxovirus-like virus isolated from pemphigus-disease in man. Arch Gesamte Virusforsch 28, 41–50.[CrossRef]
    [Google Scholar]
  59. Southern, J. A., Young, D. F., Heaney, F., Baumgärtner, W. K. & Randall, R. E. ( 1991; ). Identification of an epitope on the P and V proteins of simian virus 5 that distinguishes between two isolates with different biological characteristics. J Gen Virol 72, 1551–1557.[CrossRef]
    [Google Scholar]
  60. Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H. & Schreiber, R. D. ( 1998; ). How cells respond to interferons. Annu Rev Biochem 67, 227–264.[CrossRef]
    [Google Scholar]
  61. Thomas, S. M., Lamb, R. A. & Paterson, R. G. ( 1988; ). Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell 54, 891–902.[CrossRef]
    [Google Scholar]
  62. Tong, S., Li, M., Vincent, A., Compans, R. W., Fritsch, E., Beier, R., Klenk, C., Ohuchi, M. & Klenk, H.-D. ( 2002; ). Regulation of fusion activity by the cytoplasmic domain of a paramyxovirus F protein. Virology 301, 322–333.[CrossRef]
    [Google Scholar]
  63. Tribe, G. W. ( 1966; ). An investigation of the incidence, epidemiology and control of Simian virus 5. Br J Exp Pathol 47, 472–479.
    [Google Scholar]
  64. Tsurudome, M., Nishio, M., Komada, H., Bando, H. & Ito, Y. ( 1989; ). Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies. Virology 171, 38–48.[CrossRef]
    [Google Scholar]
  65. Ulane, C. M. & Horvath, C. M. ( 2002; ). Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 304, 160–166.[CrossRef]
    [Google Scholar]
  66. Vandvik, B. & Norrby, E. ( 1989; ). Paramyxovirus SV5 and multiple sclerosis. Nature 338, 769–771.[CrossRef]
    [Google Scholar]
  67. van Wyke Coelingh, K. L., Winter, C. C. & Murphy, B. R. ( 1988; ). Nucleotide and deduced amino acid sequence of hemagglutinin-neuraminidase genes of human type 3 parainfluenza viruses isolated from 1957 to 1983. Virology 162, 137–143.[CrossRef]
    [Google Scholar]
  68. Wallen, W. C., Sever, J. L., McFarlin, D. E., McFarland, H. F., Traub, R. G., Rentier, B., Greenstein, J. I. & Moore, P. M. ( 1979; ). Attempt to isolate infectious agent from bone-marrow of patients with multiple sclerosis. Lancet ii, 414–415.
    [Google Scholar]
  69. Wansley, E. K. & Parks, G. D. ( 2002; ). Naturally occurring substitutions in the P/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and cell death. J Virol 76, 10109–10121.[CrossRef]
    [Google Scholar]
  70. Young, D. F., Randall, R. E., Hoyle, J. A. & Souberbielle, B. E. ( 1990; ). Clearance of a persistent paramyxovirus infection is mediated by cellular immune responses but not by serum-neutralizing antibody. J Virol 64, 5403–5411.
    [Google Scholar]
  71. Young, D. F., Didcock, L., Goodbourn, S. & Randall, R. E. ( 2000; ). Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 269, 383–390.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80200-0
Loading
/content/journal/jgv/10.1099/vir.0.80200-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error